Trials / Completed
CompletedNCT04639765
Responses to Information on Treatments for Depression
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 300 (actual)
- Sponsor
- Ohio State University · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to determine the impact of different messages about depression treatments.
Detailed description
Participants recruited through Amazon Mechanical Turk (MTurk) will complete a screening questionnaire and provided the opportunity to consent to participate. Upon entry to the study, eligible participants will complete several questionnaires pre- and post-randomization. Randomization will be to view either a video detailing a type of depression treatment (cognitive behavioral therapy, antidepressant medication, or the combination of both treatments) with and without an emphasis on personalization. A no video condition is also included.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | CBT without Personalization | Intervention involves a video describing CBT without a message about personalization. |
| OTHER | CBT with Personalization | Intervention involves a video describing CBT with a message about personalization. |
| OTHER | ADM without Personalization | Intervention involves a video describing antidepressant medication without a message about personalization. |
| OTHER | ADM with Personalization | Intervention involves a video describing antidepressant medication with a message about personalization. |
| OTHER | Combined Treatment without Personalization | Intervention involves a video describing the combination of cognitive behavior therapy and antidepressant medication without a message about personalization. |
| OTHER | Combined Treatment with Personalization | Intervention involves a video describing the combination of cognitive behavior therapy and antidepressant medication with a message about personalization. |
Timeline
- Start date
- 2020-10-28
- Primary completion
- 2020-12-30
- Completion
- 2020-12-30
- First posted
- 2020-11-20
- Last updated
- 2021-09-05
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT04639765. Inclusion in this directory is not an endorsement.